177 related articles for article (PubMed ID: 10813099)
1. Inhibition of gonadotropin surge by a brief mid-cycle regimen of ethinyl estradiol and norethindrone: possible role in in vitro fertilization.
Letterie GS
Gynecol Endocrinol; 2000 Feb; 14(1):1-4. PubMed ID: 10813099
[TBL] [Abstract][Full Text] [Related]
2. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
3. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
4. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
Nuttall ID; Elstein M; Fahmy DR
Contraception; 1982 May; 25(5):463-9. PubMed ID: 6809424
[TBL] [Abstract][Full Text] [Related]
5. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
6. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of a new low-dosed combined oral contraceptive.
Dericks-Tan JS; Schneider K; Taubert HD
Arch Gynecol; 1980; 229(2):107-14. PubMed ID: 6768343
[TBL] [Abstract][Full Text] [Related]
8. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
[TBL] [Abstract][Full Text] [Related]
9. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies on the positive feedback effect of progesterone, 17 alpha-hydroxyprogesterone and 20 alpha-dihydroprogesterone on the pituitary release of LH and FSH in the human female. The estrogen priming of the progesterone feedback on pituitary gonadotropins in the eugonadal woman.
Leyendecker G; Wildt L; Gips H; Nocke W; Plotz EJ
Arch Gynakol; 1976; 221(1):29-45. PubMed ID: 989265
[TBL] [Abstract][Full Text] [Related]
11. Ovarian activity during regular oral contraceptive use.
Crosignani PG; Testa G; Vegetti W; Parazzini F
Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
[TBL] [Abstract][Full Text] [Related]
12. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.
Rible RD; Taylor D; Wilson ML; Stanczyk FZ; Mishell DR
Contraception; 2009 Mar; 79(3):182-8. PubMed ID: 19185670
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
15. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
16. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
Elomaa K; Lähteenmäki P
Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women.
Kumar TC; Shah RS; Chitlange SM; Hazari KT; Gopalkrishnan K; Vadigoppula AD; Vernekar VJ; Borkar DM; Puri CP
Contraception; 1991 Sep; 44(3):245-67. PubMed ID: 1764942
[TBL] [Abstract][Full Text] [Related]
18. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers.
Haughian JM; Ginther OJ; Diaz FJ; Wiltbank MC
Biol Reprod; 2013 Jun; 88(6):165. PubMed ID: 23658431
[TBL] [Abstract][Full Text] [Related]
20. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
Croxatto HB; Brache V; Massai R; Alvarez F; Forcelledo ML; Pavez M; Cochon L; Salvatierra AM; Faundes A
Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]